Effect of ginsenoside Rg1 on hematopoietic stem cells in treating aplastic anemia in mice via MAPK pathway

Figure 6 Ginsenoside Rg1 alleviated myelosuppression in mice by inhibiting MAPK signaling pathway in vivo and in vitro. A: Western blot was used to detect the expression of p-p38, p38, p-JNK, JNK, p-ERK, and ERK in different groups in vivo, the endogenous control used was β-actin; B: Quantification of western blot images, ^aP < 0.05, ^bP < 0.01, compared to the control group; ^cP < 0.05, ^dP < 0.01, compared to the cyclophosphamide (CTX) group; C: Western blot was used to detect the expression of p-p38, p38, p-JNK, JNK, p-ERK, and ERK in different groups in vitro, the endogenous control used was β-Actin; D: Quantification of western blot images, ^bP < 0.01, compared to the normal group; ^cP < 0.05, ^dP < 0.01, compared to the aplastic anemia (AA) group.